Quantifying Hypoxia with Radiolabeled Fluoromisonidazole: Pre-Clinical and Clinical Studies
- 1 January 1999
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Tumor Oxygenation: A New Predictive Parameter in Locally Advanced Cancer of the Uterine CervixGynecologic Oncology, 1993
- Imaging of hypoxia in human tumors with [F-18]fluoromisonidazoleInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Exercise-induced myocardial ischemia. Importance of coronary blood flow.Circulation, 1991
- Synthesis of an (iodovinyl)misonidazole derivative for hypoxia imagingJournal of Medicinal Chemistry, 1991
- Importance of thiols in the reductive binding of 2-nitroimidazoles to macromoleculesBiochemical Pharmacology, 1990
- Fluoromisonidazole. A metabolic marker of myocyte hypoxia.Circulation Research, 1990
- Deoxyglucose Lumped Constant Estimated in a Transplanted Rat Astrocytic Glioma by the Hexose Utilization IndexJournal of Cerebral Blood Flow & Metabolism, 1990
- Synthesis and biodistribution of 18F-labeled fluoronitroimidazoles: Potential in vivo markers of hypoxic tissueApplied Radiation and Isotopes, 1986
- The biological properties of reduced nitroheterocyclics and possible underlying biochemical mechanismsBiochemical Pharmacology, 1986
- RADIOTHERAPY AND HYPERBARIC OXYGEN IN HEAD AND NECK CANCERThe Lancet, 1977